These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17339177)

  • 1. The metabolic syndrome and the risk of thrombosis.
    Dentali F; Romualdi E; Ageno W
    Haematologica; 2007 Mar; 92(3):297-9. PubMed ID: 17339177
    [No Abstract]   [Full Text] [Related]  

  • 2. Venous thromboembolism--a manifestation of the metabolic syndrome.
    Ay C; Tengler T; Vormittag R; Simanek R; Dorda W; Vukovich T; Pabinger I
    Haematologica; 2007 Mar; 92(3):374-80. PubMed ID: 17339187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation, obesity, and thrombosis.
    Samad F; Ruf W
    Blood; 2013 Nov; 122(20):3415-22. PubMed ID: 24092932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicle markers in relation to obesity and metabolic complications in patients with manifest cardiovascular disease.
    Kranendonk ME; de Kleijn DP; Kalkhoven E; Kanhai DA; Uiterwaal CS; van der Graaf Y; Pasterkamp G; Visseren FL;
    Cardiovasc Diabetol; 2014 Feb; 13():37. PubMed ID: 24498934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.
    Goralski KB; Sinal CJ
    Can J Physiol Pharmacol; 2007 Jan; 85(1):113-32. PubMed ID: 17487251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and inflammation, two features associated with a high percentage body fat, and that may lead to diabetes mellitus and metabolic syndrome.
    Darroudi S; Fereydouni N; Tayefi M; Ahmadnezhad M; Zamani P; Tayefi B; Kharazmi J; Tavalaie S; Heidari-Bakavoli A; Azarpajouh MR; Ferns GA; Mohammadpour AH; Esmaily H; Ghayour-Mobarhan M
    Biofactors; 2019 Jan; 45(1):35-42. PubMed ID: 30561055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis of metabolic syndrome].
    Nakamura T; Okauchi Y; Ryo M; Funahashi T; Shimomura I
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1731-6. PubMed ID: 17037307
    [No Abstract]   [Full Text] [Related]  

  • 8. [The prevalence of metabolic syndrome in middle-aged in Kaunas population].
    Gustiene O; Slapikas R; Klumbiene J; Sakalauskiene G; Kubilius R; Bagdzeviciūte S; Zaliūnas R
    Medicina (Kaunas); 2005; 41(10):867-76. PubMed ID: 16272835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults.
    Mangge H; Zelzer S; Puerstner P; Schnedl WJ; Reeves G; Postolache TT; Weghuber D
    Obesity (Silver Spring); 2013 Jan; 21(1):E71-7. PubMed ID: 23401248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the metabolic syndrome? Prediabetes and cardiovascular risk.
    Borgman M; McErlean E
    J Cardiovasc Nurs; 2006; 21(4):285-90. PubMed ID: 16823282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome: a marker of patients at high cardiovascular risk.
    Lau DC; Yan H; Dhillon B
    Can J Cardiol; 2006 Feb; 22 Suppl B(Suppl B):85B-90B. PubMed ID: 16498518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic syndrome as a prohypertensive state.
    Mulé G; Cerasola G
    Am J Hypertens; 2008 Jan; 21(1):8. PubMed ID: 18268791
    [No Abstract]   [Full Text] [Related]  

  • 13. 25-OH vitamin D: is it the universal panacea for metabolic syndrome and type 2 diabetes?
    Osei K
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4220-2. PubMed ID: 20823471
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study.
    Ballantyne CM; Hoogeveen RC; McNeill AM; Heiss G; Schmidt MI; Duncan BB; Pankow JS
    Int J Obes (Lond); 2008 May; 32 Suppl 2(Suppl 2):S21-4. PubMed ID: 18469836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Macro- and microvascular disease in type 2 diabetes mellitus].
    Cases A
    Nefrologia; 2002; 22(5):406-11. PubMed ID: 12497740
    [No Abstract]   [Full Text] [Related]  

  • 16. Anthropometric measurements in childhood and prediction of cardiovascular risk factors in adulthood: Kaunas cardiovascular risk cohort study.
    Petkeviciene J; Klumbiene J; Kriaucioniene V; Raskiliene A; Sakyte E; Ceponiene I
    BMC Public Health; 2015 Mar; 15():218. PubMed ID: 25880559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secular Trend of Metabolic Syndrome and Its Components in a Cohort of Iranian Adults from 2001 to 2013.
    Khosravi-Boroujeni H; Sarrafzadegan N; Sadeghi M; Roohafza H; Talaei M; Ng SK; Phung H; Pourmogaddas A; Ahmed F
    Metab Syndr Relat Disord; 2017 Apr; 15(3):137-144. PubMed ID: 28135122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relations between hemostatic variables, insulin resistance and inflammation.
    Morange PE; Alessi MC; Juhan-Vague I
    Hematol J; 2004; 5 Suppl 3():S15-9. PubMed ID: 15190271
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management.
    Grundy SM; Hansen B; Smith SC; Cleeman JI; Kahn RA; ; ;
    Circulation; 2004 Feb; 109(4):551-6. PubMed ID: 14757684
    [No Abstract]   [Full Text] [Related]  

  • 20. [Metabolic syndrome. Joint declaration, October 2009].
    Gutiérrez Fuentes JA
    Endocrinol Nutr; 2009 Dec; 56 Suppl 4():67-9. PubMed ID: 20629238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.